首页> 美国卫生研究院文献>International Journal of Nanomedicine >Preparation and evaluation of tilmicosin-loaded hydrogenated castor oil nanoparticle suspensions of different particle sizes
【2h】

Preparation and evaluation of tilmicosin-loaded hydrogenated castor oil nanoparticle suspensions of different particle sizes

机译:负载替米考星的氢化蓖麻油纳米粒子悬浮液的制备与评价

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Three tilmicosin-loaded hydrogenated castor oil nanoparticle (TMS-HCO-NP) suspensions of different particle sizes were prepared with different polyvinyl alcohol surfactant concentrations using a hot homogenization and ultrasonic technique. The in vitro release, in vitro antibacterial activity, mammalian cytotoxicity, acute toxicity in mice, and stability study were conducted to evaluate the characteristics of the suspensions. The in vitro tilmicosin release rate, antibacterial activity, mammalian cytotoxicity, acute toxicity in mice, and stability of the suspensions were evaluated. When prepared with polyvinyl alcohol concentrations of 0.2%, 1%, and 5%, the mean diameters of the nanoparticles in the three suspensions were 920±35 nm, 452±10 nm, and 151±4 nm, respectively. The three suspensions displayed biphasic release profiles similar to that of freeze-dried TMS-HCO-NP powders, with the exception of having a faster initial release. Moreover, suspensions of smaller-sized particles showed faster initial release, and lower minimum inhibitory concentrations and minimum bactericidal concentrations. Time-kill curves showed that within 12 hours, the suspension with the 151 nm particles had the most potent bactericidal activity, but later, the suspensions with larger-sized particles showed increased antibacterial activity. None of the three suspensions were cytotoxic at clinical dosage levels. At higher drug concentrations, all three suspensions showed similar concentration-dependent cytotoxicity. The suspension with the smallest-sized particle showed significantly more acute toxicity in mice, perhaps due to faster drug release. All three suspensions exhibited good stability at 4°C and at room temperature for at least 6 months. These results demonstrate that TMS-HCO-NP suspensions can be a promising formulation for tilmicosin, and that nanoparticle size can be an important consideration for formulation development.
机译:使用热均化和超声技术,用不同的聚乙烯醇表面活性剂浓度制备了三种不同粒径的加载有替米考辛的氢化蓖麻油纳米粒子(TMS-HCO-NP)悬浮液。进行了体外释放,体外抗菌活性,哺乳动物细胞毒性,小鼠急性毒性和稳定性研究,以评估悬浮液的特性。评价了体外替米考星的释放速率,抗菌活性,哺乳动物细胞毒性,小鼠急性毒性以及悬浮液的稳定性。当使用浓度为0.2%,1%和5%的聚乙烯醇制备时,三种悬浮液中纳米颗粒的平均直径分别为920±35 nm,452±10 nm和151±4 nm。三种悬浮液显示出与冷冻干燥的TMS-HCO-NP粉末相似的双相释放曲线,不同之处在于其初始释放速度更快。而且,较小尺寸的颗粒的悬浮液显示出较快的初始释放,以及较低的最低抑菌浓度和最低杀菌浓度。时间-杀灭曲线显示,在12小时内,具有151 nm颗粒的悬浮液具有最强的杀菌活性,但后来,具有较大颗粒的悬浮液显示出增强的抗菌活性。三种悬浮液在临床剂量水平均无细胞毒性。在较高的药物浓度下,所有三种悬浮液均表现出相似的浓度依赖性细胞毒性。具有最小尺寸颗粒的悬浮液在小鼠中显示出明显更高的急性毒性,这可能是由于药物释放更快。所有这三种悬浮液在4°C和室温下至少6个月都表现出良好的稳定性。这些结果表明,TMS-HCO-NP悬浮液可能是有前途的替米考星制剂,而纳米颗粒的大小可能是制剂开发的重要考虑因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号